United States · Series A startup

Who invested in Capacity Bio

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2023, from 2 sources

Latest round
Series A, $35MMar 2023
Investors
3
See who backed them

The rounds

  1. Mar 2023
    Series A$35M

    Reported by Firms' own news pages and 1 otherSEC filing: $19M sold, first sale Dec 2022

Founders and team

From Capacity Bio's own website and the SEC filings it signed: 8 on the team.

  • Ken HorneChief Executive Officer
  • Aaron BergenerChief Financial Officer
  • Masanobu UchidaChief Development Officer
  • Noriko KanaiChief Financial Officer
  • Amy WangExecutive Officer, Directori
  • Dylan MorrisBoard Member
  • Kenneth HorneExecutive Officer, Directori
  • Taro InabaBoard Member

On the board, as filediCristina Ghenoiu

Everyone who backed them

Insight PartnersVC firm1round
RA Capital ManagementPrivate equity1round
Remiges VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Capacity Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

AN Venture PartnersVC firmPer its own site

Quick answers about Capacity Bio

Who invested in Capacity Bio?

Capacity Bio's investors include Insight Partners, RA Capital Management and Remiges Ventures.

How much has Capacity Bio raised?

Capacity Bio has raised $35M across 1 round since 2023.

When did Capacity Bio last raise?

Capacity Bio's most recent round was a Series A of $35M in Mar 2023.

What was Capacity Bio's biggest round?

Its most recent round, $35M in Mar 2023, is also its largest on record.

Who backed Capacity Bio first?

Capacity Bio's first round on record, in Mar 2023, was backed by Insight Partners, RA Capital Management and Remiges Ventures.

What stage is Capacity Bio at?

Capacity Bio's latest named round is a Series A, in Mar 2023.

Where is Capacity Bio based?

Capacity Bio is based in the United States.

Companies like Capacity Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.